CRL Charles River Laboratories International, Inc. Common Stock

NYSE · Life Sciences Tools & Services · View on SEC EDGAR ↗

$150.86

Price · May 20, 2026

Fundamentals as of May 7, 2026

CRL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$150.85

Market Cap

$10.02B

P/E (TTM)

-70.0

EPS (TTM)

$-2.91

Revenue (TTM)

$4.02B

Div Yield

—

ROE

-4.4%

Debt/Equity

0.0

52W Range

$133 – $229

CRL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $4.02B

2016-12-31 → 2025-12-27

EPS $-2.91

2016-12-31 → 2025-12-27

Free Cash Flow $518M

2016-12-31 → 2025-12-27

Margins -3.6%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

CRL

Peer Median

P/E (TTM)

-70.0

37.6

P/S (TTM)

2.5

5.5

P/B

3.2

4.2

EV / EBITDA

22.9

—

Price / FCF

19.3

—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

CRL

Peer Median

Operating Margin

0.63%

—

Net Profit Margin

-3.6%

11.7%

ROA

-2.0%

4.7%

ROE

-4.4%

7.4%

ROIC

1.1%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

CRL

Peer Median

Debt / Equity

0.0

20.5

Current Ratio

1.3

2.5

Quick Ratio

0.8

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

CRL

Peer Median

Revenue YoY

-0.85%

—

Revenue CAGR 3Y

0.33%

—

Revenue CAGR 5Y

6.6%

—

EPS YoY

-97.8%

—

Net Income YoY

-95.3%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

CRL

Peer Median

EPS (Diluted)

$-2.91

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

CRL

Peer Median

CRL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 24 analysts

Strong Buy 7 29.2%
Buy 8 33.3%
Hold 9 37.5%
Sell 0 0.0%
Strong Sell 0 0.0%

12-Month Price Target

15 analysts · 2026-05-15

Median $220.00

Mean $208.80

Now $150.85

Low $135.00

High $265.00

Median target $220.00 +45.8%

Mean target $208.80 +38.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

0.21%

Period	EPS Actual	EPS Est	Surprise
March 31, 2026	$2.06	$1.96	0.10%
Dec. 31, 2025	$2.39	$2.37	0.02%
Sept. 30, 2025	$2.43	$2.36	0.07%
June 30, 2025	$3.12	$2.52	0.60%
March 31, 2025	$2.34	$2.10	0.24%

Peer Comparison Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	—
TEM	—	-41.9	83.4%	-19.3%	-61.2%	—
MEDP	$15.93B	36.8	20.0%	17.8%	142.9%	—
RVTY	$10.86B	46.7	3.7%	8.5%	3.3%	—
TEM	—	-41.9	83.4%	-19.3%	-61.2%	—
BIO	—	—	—	—	—	—
TECH	$7.97B	111.8	5.2%	6.0%	3.7%	64.8%
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	—
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15

Annual Income Statement data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$4.02B	$4.05B	$4.13B	$3.98B	$3.54B	$2.92B	$2.62B	$2.27B	$1.86B	$1.68B	$1.36B	$1.30B
Cost of Revenue	·	·	·	·	·	·	·	·	$290M	$277M	$264M	$266M
SG&A Expense	$743M	$751M	$748M	$665M	$620M	$529M	$518M	$444M	$371M	$365M	$300M	$269M
Operating Income	$25M	$227M	$617M	$651M	$590M	$433M	$351M	$331M	$288M	$238M	$206M	$178M
Interest Expense	·	·	$137M	$59M	$74M	$86M	$61M	$64M	$30M	$28M	$15M	$12M
Interest Income	$5M	$9M	$5M	$780.0K	$652.0K	$834.0K	$2M	$812.0K	$690.0K	$1M	$1M	$1M
Other Non-op	$-23M	$-17M	$96M	$31M	$-36M	$100M	$12M	$13M	$38M	$12M	$3M	$11M
Pretax Income	$-100M	$93M	$581M	$623M	$481M	$447M	$304M	$282M	$297M	$223M	$195M	$178M
Income Tax	$43M	$68M	$101M	$130M	$82M	$82M	$50M	$54M	$171M	$67M	$43M	$48M
Net Income	$-144M	$22M	$475M	$486M	$391M	$364M	$252M	$226M	$123M	$155M	$149M	$127M
EPS (Basic)	$-2.91	$0.20	$9.27	$9.57	$7.77	$7.35	$5.17	$4.72	$2.60	$3.29	$3.21	$2.72
EPS (Diluted)	$-2.91	$0.20	$9.22	$9.48	$7.60	$7.20	$5.07	$4.62	$2.54	$3.23	$3.13	$2.66
Shares (Basic)	49,564,000	51,380,000	51,227,000	50,812,000	50,293,000	49,550,000	48,730,000	47,947,000	47,481,000	47,014,000	46,496,000	46,627,000
Shares (Diluted)	49,564,000	51,628,000	51,451,000	51,301,000	51,425,000	50,611,000	49,693,000	49,018,000	48,564,000	47,958,000	47,634,000	47,558,000
EBITDA	$428M	$589M	$931M	$955M	$855M	$668M	$549M	$493M	$419M	$364M	$301M	$274M

Balance Sheet 30

Annual Balance Sheet data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$214M	$195M	$277M	$234M	$241M	$228M	$238M	$195M	$164M	$118M	$118M	$160M
Short-term Investments	·	·	·	·	$1M	$1M	$941.0K	$885.0K	$28M	$4M	$21M	·
Receivables	$709M	$721M	$780M	$752M	$643M	$618M	$514M	$472M	$430M	$364M	$270M	$258M
Inventory	$299M	$279M	$380M	$256M	$199M	$186M	$161M	$128M	$115M	$96M	$94M	$89M
Prepaid Expense	$129M	$106M	$83M	$108M	$97M	$73M	$56M	$49M	$81M	$45M	$47M	$45M
Other Current Assets	·	·	·	·	·	$0	$300.0K	$300.0K	$0	$45M	$47M	$73M
Current Assets	$1.45B	$1.40B	$1.61B	$1.44B	$1.27B	$1.20B	$1.02B	$898M	$827M	$657M	$559M	$579M
PP&E (Net)	$1.66B	$1.60B	$1.64B	$1.47B	$1.29B	$1.12B	$1.04B	$933M	$782M	$756M	$678M	$677M
PP&E (Gross)	$3.19B	$3.06B	$2.98B	$2.63B	$2.39B	$2.21B	$2.02B	$1.81B	$1.58B	$1.46B	$1.32B	$1.33B
Accum. Depreciation	$1.54B	$1.45B	$1.34B	$1.16B	$1.10B	$1.09B	$978M	$874M	$801M	$706M	$645M	$655M
Goodwill	$2.76B	$2.85B	$3.10B	$2.85B	$2.71B	$1.81B	$1.54B	$1.25B	$805M	$788M	$439M	$321M
Intangibles	$340M	$723M	$864M	$955M	$1.06B	$788M	$689M	$611M	$370M	$394M	$281M	$281M
Other Non-current Assets	$293M	$278M	$309M	$148M	$152M	$353M	$213M	$144M	$124M	$88M	$72M	$73M
Total Assets	$7.14B	$7.53B	$8.20B	$7.60B	$7.02B	$5.49B	$4.69B	$3.86B	$2.93B	$2.71B	$2.07B	$1.87B
Accounts Payable	$149M	$140M	$169M	$206M	$198M	$122M	$111M	$66M	$78M	$68M	$37M	$34M
Accrued Liabilities	$270M	$232M	$228M	$220M	$229M	$150M	$139M	$107M	$90M	$84M	$89M	$67M
Current Liabilities	$1.12B	$994M	$1.06B	$1.09B	$1.03B	$840M	$710M	$558M	$464M	$430M	$312M	$295M
Capital Leases	$434M	$484M	$419M	$390M	$253M	$156M	$116M	·	·	·	·	·
Deferred Tax	$95M	$107M	$191M	$216M	$240M	$217M	$167M	$144M	$90M	$56M	$48M	$23M
Other Non-current Liabilities	$138M	$195M	$223M	$175M	$243M	$205M	$183M	$179M	$195M	$159M	$89M	$100M
Total Liabilities	$3.92B	$4.02B	$4.54B	$4.58B	$4.43B	$3.35B	$3.03B	$2.52B	$1.87B	$1.86B	$1.30B	$1.17B
Long-term Debt	·	·	·	·	·	·	·	$1.61B	$1.09B	$1.18B	$814M	$717M
Total Debt	$166.0K	$155.0K	$3M	$1M	$101.0K	$47M	$36M	$1.65B	$1.12B	$1.21B	$836M	$754M
Common Stock	$492.0K	$511.0K	$513.0K	$509.0K	$505.0K	$498.0K	$489.0K	$482.0K	$875.0K	$863.0K	$855.0K	$845.0K
Retained Earnings	$1.39B	$1.81B	$1.89B	$1.43B	$981M	$625M	$280M	$42M	$289M	$165M	$11M	$-139M
Treasury Stock	$0	$0	$0	$0	$0	$0	$0	$55.0K	$1.66B	$1.55B	$1.54B	$1.42B
AOCI	$-172M	$-317M	$-196M	$-262M	$-165M	$-139M	$-178M	$-173M	$-145M	$-254M	$-136M	$-74M
Stockholders' Equity	$3.16B	$3.46B	$3.60B	$2.98B	$2.53B	$2.11B	$1.63B	$1.32B	$1.05B	$837M	$733M	$672M
Liabilities + Equity	$7.14B	$7.53B	$8.20B	$7.60B	$7.02B	$5.49B	$4.69B	$3.86B	$2.93B	$2.71B	$2.07B	$1.87B
Shares Outstanding	49,217,000	51,141,000	51,338,000	50,944,000	50,480,000	49,767,000	48,936,000	48,209,000	47,402,000	47,363,000	46,698,000	47,327,000

Cash Flow 18

Annual Cash Flow data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$403M	$362M	$314M	$304M	$266M	$235M	$198M	$162M	$131M	$127M	$95M	$96M
Stock-based Comp	$71M	$70M	$72M	$74M	$71M	$56M	$57M	$47M	$44M	$44M	$40M	$31M
Deferred Tax	$-75M	$-67M	$-51M	$-33M	$-20M	$2M	$-21M	$-10M	$28M	$3M	$4M	$9M
Amort. of Intangibles	$179M	$138M	$137M	$147M	$125M	$112M	$90M	$65M	$41M	$42M	$24M	$26M
Restructuring	$100M	$107M	$30M	$8M	$7M	$13M	$14M	$10M	$5M	$18M	$8M	$8M
Other Non-cash	$483M	$348M	$-126M	$-211M	$53M	$-111M	$-5M	$16M	$-8M	$-28M	$-395.0K	·
Operating Cash Flow	$738M	$735M	$684M	$620M	$761M	$547M	$481M	$441M	$318M	$317M	$307M	$252M
CapEx	$219M	$233M	$319M	$325M	$229M	$167M	$141M	$140M	$82M	$55M	$63M	$57M
Investing Cash Flow	$-209M	$-245M	$-563M	$-608M	$-1.44B	$-602M	$-682M	$-955M	$-73M	$-693M	·	·
Debt Issued	$1.23B	$1.08B	$776M	$2.95B	$6.95B	$2.23B	$3.36B	$2.76B	$237M	$1.04B	·	·
Net Debt Issued	$1.23B	$1.08B	$776M	$2.95B	$6.95B	$2.23B	$3.36B	$2.76B	·	·	·	·
Stock Repurchased	$361M	$119M	$24M	$39M	$41M	$24M	$18M	$14M	$107M	$12M	$117M	$122M
Net Stock Activity	$-361M	$-119M	$-24M	$-39M	$-41M	$-24M	$-18M	$-14M	$-107M	$-12M	$-117M	$-122M
Financing Cash Flow	$-537M	$-551M	$-86M	$-42M	$673M	$47M	$232M	$558M	$-208M	$381M	·	·
Net Change in Cash	$10M	$-79M	$43M	$-5M	$13M	$-7M	$43M	$31M	$46M	$-69.0K	$-43M	$4M
Taxes Paid	$120M	$126M	$90M	$76M	$75M	$60M	$54M	$68M	·	·	·	·
Free Cash Flow	$518M	$502M	$365M	$295M	$532M	$380M	$340M	$301M	$236M	$245M	$225M	$195M
Levered FCF	·	·	$252M	$248M	$471M	$309M	$290M	$250M	$223M	$226M	$213M	$186M

Profitability 7

Annual Profitability data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	0.63%	5.6%	14.9%	16.4%	16.7%	14.8%	13.4%	14.6%	15.5%	14.1%	15.1%	13.7%
Net Margin	-3.6%	0.55%	11.5%	12.2%	11.0%	12.5%	9.6%	10.0%	6.6%	9.2%	10.9%	·
Pretax Margin	-2.5%	2.3%	14.1%	15.7%	13.6%	15.3%	11.6%	12.4%	16.0%	13.3%	14.3%	13.7%
EBITDA Margin	10.7%	14.5%	22.6%	24.0%	24.2%	22.8%	20.9%	21.8%	22.5%	21.6%	22.1%	21.1%
ROA	-2.0%	0.28%	6.0%	6.7%	6.2%	7.1%	5.9%	6.7%	4.4%	6.5%	7.6%	·
ROE	-4.4%	0.63%	14.4%	17.6%	16.8%	19.4%	17.1%	19.2%	13.1%	19.7%	21.2%	·
ROIC	1.1%	1.8%	14.2%	17.3%	19.3%	16.4%	17.6%	9.0%	5.6%	8.1%	10.2%	9.1%

Liquidity & Solvency 5

Annual Liquidity & Solvency data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.3	1.4	1.5	1.3	1.2	1.4	1.4	1.6	1.8	1.5	1.8	2.0
Quick Ratio	0.8	0.9	1.0	0.9	0.9	1.0	1.1	1.2	1.3	1.1	1.2	1.4
Debt / Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.4	1.1	1.1
LT Debt / Equity	·	·	·	·	·	·	·	1.2	1.0	1.4	1.1	1.1
Interest Coverage	·	·	4.5	11.0	8.0	5.0	5.8	5.2	9.7	8.6	13.7	14.9

Efficiency 3

Annual Efficiency data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	0.7	0.7	0.7	0.7	0.7
Inventory Turnover	·	·	·	·	·	·	·	·	2.7	2.9	2.9	3.0
Receivables Turnover	5.6	5.4	5.4	5.7	5.6	5.2	5.3	5.0	4.7	5.3	5.2	5.4

Per Share 5

Annual Per Share data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$64.30	$67.69	$70.06	$58.42	$50.21	$42.49	$33.40	$27.33	$22.05	$17.67	$15.70	$14.20
Revenue / Share	$81.01	$78.45	$80.26	$77.50	$68.84	$57.77	$52.75	$46.23	$38.25	$35.06	·	·
Cash Flow / Share	$14.88	$14.23	$13.29	$12.08	$14.79	$10.80	$9.68	$9.00	$6.55	$6.26	·	·
Cash / Share	$4.34	$3.81	$5.39	$4.59	$4.78	$4.59	$4.86	$4.05	$3.46	$2.48	$2.53	$3.38
EPS (TTM)	$-2.91	$0.20	$9.22	$9.48	$7.60	$7.20	$5.07	$4.62	$2.54	$3.23	$3.13	$2.66

Growth Rates 7

Annual Growth Rates data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-0.85%	-1.9%	3.9%	12.3%	21.1%	·	·	·	·	·	·	·
Revenue CAGR 3Y	0.33%	4.6%	12.2%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	6.6%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	·	-97.8%	-2.7%	24.7%	5.6%	·	·	·	·	·	·	·
EPS CAGR 3Y	·	-70.3%	8.6%	·	·	·	·	·	·	·	·	·
Net Income YoY	·	-95.3%	-2.4%	24.4%	7.3%	·	·	·	·	·	·	·
Net Income CAGR 3Y	·	-61.6%	9.2%	·	·	·	·	·	·	·	·	·

Valuation (TTM) 14

Annual Valuation (TTM) data for CRL
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$4.02B	$4.05B	$4.13B	$3.98B	$3.54B	$2.92B	$2.62B	$2.27B	$1.86B	$1.68B	$1.36B	$1.30B
Net Income TTM	$-144M	$22M	$475M	$486M	$391M	$364M	$252M	$226M	$123M	$155M	$149M	$127M
Market Cap	$10.02B	$9.52B	$12.14B	$11.10B	$18.64B	$12.53B	$7.43B	$5.39B	$5.19B	$3.61B	$3.74B	$3.04B
Enterprise Value	$9.81B	$9.33B	$11.86B	$10.87B	$18.40B	$12.34B	$7.23B	$6.84B	$6.12B	$4.70B	$4.46B	$3.64B
P/E	-70.0	930.8	25.6	23.0	48.6	35.0	30.0	24.2	43.1	23.6	25.6	24.2
P/S	2.5	2.4	2.9	2.8	5.3	4.3	2.8	2.4	2.8	2.1	2.7	2.3
P/B	3.2	2.8	3.4	3.7	7.4	5.9	4.5	4.1	5.0	4.3	5.1	4.5
P / Tangible Book	166.0	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	13.6	13.0	17.7	17.9	24.5	22.9	15.5	12.2	16.3	12.0	13.0	12.1
P / FCF	19.3	19.0	33.2	37.6	35.0	33.0	21.8	17.9	22.0	14.7	16.6	15.6
EV / EBITDA	22.9	15.8	12.7	11.4	21.5	18.5	13.2	13.9	14.6	12.9	14.8	13.3
EV / FCF	18.9	18.6	32.5	36.9	34.6	32.5	21.2	22.7	26.0	19.2	19.8	18.6
EV / Revenue	2.4	2.3	2.9	2.7	5.2	4.2	2.8	3.0	3.3	2.8	3.3	2.8
Earnings Yield	-1.4%	0.11%	3.9%	4.3%	2.1%	2.9%	3.3%	4.1%	2.3%	4.2%	3.9%	4.1%

Income Statement 14

Quarterly Income Statement data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$996M	$994M	$1.00B	$1.03B	$984M	$1.00B	$1.01B	$1.03B	$1.01B	$1.01B	$1.03B	$1.06B	$1.03B	$1.10B	$989M	$973M
Cost of Revenue	·	·	·	·	·	·	$661M	$672M	$667M	·	$665M	$661M	$652M	·	·	·
SG&A Expense	$159M	$196M	$178M	$192M	$178M	$196M	$199M	$170M	$186M	$197M	$176M	$200M	$175M	$200M	$184M	$132M
Operating Income	$120M	$-283M	$134M	$100M	$75M	$-168M	$117M	$152M	$126M	$133M	$152M	$165M	$168M	$164M	$151M	$187M
Interest Expense	·	·	·	·	·	·	·	·	$35M	·	$34M	$35M	$34M	·	$11M	$4M
Interest Income	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$3M	$2M	$2M	$1M	$1M	$806.0K	$343.0K	$122.0K	$188.0K
Other Non-op	$-124M	$12M	$-23M	$154.0K	$-12M	$-23M	$3M	$-2M	$6M	$108M	$-6M	$-3M	$-3M	$116M	$-17M	$-40M
Income Tax	$-15M	$-18M	$32M	$19M	$10M	$-3M	$21M	$25M	$25M	$20M	$25M	$29M	$27M	$56M	$25M	$33M
Net Income	$-15M	$-277M	$54M	$52M	$25M	$-214M	$70M	$94M	$73M	$187M	$87M	$97M	$103M	$187M	$96M	$109M
EPS (Basic)	$-0.30	$-5.58	$1.11	$1.06	$0.50	$-4.20	$1.34	$1.75	$1.31	$3.65	$1.70	$1.89	$2.02	$3.68	$1.90	$2.15
EPS (Diluted)	$-0.30	$-5.57	$1.10	$1.06	$0.50	$-4.17	$1.33	$1.74	$1.30	$3.64	$1.69	$1.89	$2.01	$3.66	$1.88	$2.13
Shares (Basic)	48,951,000	-99,475,000	49,213,000	49,149,000	50,677,000	-103,002,000	51,394,000	51,551,000	51,437,000	28,000	51,283,000	51,216,000	51,097,000	-101,521,000	50,870,000	50,823,000
Shares (Diluted)	48,951,000	-100,031,000	49,426,000	49,316,000	50,853,000	-103,643,000	51,583,000	51,846,000	51,842,000	-42,000	51,607,000	51,467,000	51,428,000	-102,590,000	51,283,000	51,283,000
EBITDA	$187M	·	$219M	$220M	$195M	·	$206M	$238M	$211M	·	$230M	$243M	$245M	·	$226M	$264M

Balance Sheet 28

Quarterly Balance Sheet data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$192M	$214M	$207M	$183M	$229M	$195M	$210M	$179M	$327M	·	$157M	$200M	$202M	·	$194M	$200M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$950.0K	$1M
Receivables	$700M	$709M	$734M	$768M	$757M	$721M	$754M	$762M	$787M	·	$799M	$801M	$788M	·	$771M	$748M
Inventory	$360M	$299M	$303M	$280M	$290M	$279M	$336M	$349M	$361M	·	$293M	$285M	$263M	·	$262M	$257M
Prepaid Expense	$135M	$129M	$166M	$130M	$100M	$106M	$102M	$111M	$99M	·	$93M	$113M	$92M	·	$97M	$107M
Current Assets	$1.49B	$1.45B	$1.53B	$1.47B	$1.51B	$1.40B	$1.49B	$1.50B	$1.67B	·	$1.44B	$1.50B	$1.45B	·	$1.42B	$1.39B
PP&E (Net)	$1.51B	$1.66B	$1.59B	$1.61B	$1.59B	$1.60B	·	·	·	·	·	·	·	·	·	·
PP&E (Gross)	$2.94B	$3.19B	$3.09B	$3.10B	$3.05B	$3.06B	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$1.43B	$1.54B	$1.50B	$1.50B	$1.46B	$1.45B	·	·	·	·	·	·	·	·	·	·
Goodwill	$3.04B	$2.76B	$2.92B	$2.94B	$2.87B	$2.85B	$3.12B	$3.08B	$3.07B	·	$2.88B	$2.92B	$2.90B	·	$2.78B	$2.86B
Intangibles	$249M	$340M	$571M	$602M	$656M	$723M	$778M	$800M	$828M	·	$886M	$930M	$958M	·	$968M	$1.03B
Other Non-current Assets	$826M	$293M	$291M	$296M	$294M	$278M	$307M	$301M	$303M	·	$155M	$155M	$154M	·	$430M	$436M
Total Assets	$7.73B	$7.14B	$7.51B	$7.56B	$7.58B	$7.53B	$8.00B	$7.95B	$8.15B	·	$7.61B	$7.77B	$7.70B	·	$7.38B	$7.53B
Accounts Payable	$134M	$149M	$170M	$146M	$149M	$140M	$136M	$133M	$130M	·	$136M	$140M	$120M	·	$182M	$211M
Accrued Liabilities	$372M	$270M	$229M	$232M	$242M	$232M	$208M	$192M	$191M	·	$198M	$221M	$221M	·	$197M	$199M
Current Liabilities	$1.09B	$1.12B	$1.12B	$1.08B	$1.05B	$994M	$1.01B	$948M	$955M	·	$994M	$1.01B	$981M	·	$1.01B	$1.05B
Capital Leases	$393M	$434M	$443M	$454M	$475M	$484M	$433M	$429M	$418M	·	$390M	$402M	$418M	·	$369M	$366M
Deferred Tax	$81M	$95M	$123M	$109M	$107M	$107M	$168M	$165M	$180M	·	$185M	$207M	$212M	·	$196M	$230M
Other Non-current Liabilities	$511M	$138M	$189M	$185M	$196M	$195M	$237M	$225M	$235M	·	$173M	$177M	$187M	·	$195M	$195M
Total Liabilities	$4.74B	$3.92B	$4.06B	$4.16B	$4.34B	$4.02B	$4.18B	$4.18B	$4.45B	·	$4.26B	$4.47B	$4.54B	·	$4.71B	$4.84B
Total Debt	$7M	·	$54.0K	$98.0K	$121.0K	·	$157.0K	$435.0K	$459.0K	·	$797.0K	·	·	·	$0	$95.0K
Common Stock	$493.0K	$492.0K	$514.0K	$513.0K	$512.0K	$511.0K	$517.0K	$517.0K	$515.0K	·	$514.0K	$513.0K	$512.0K	·	$510.0K	$510.0K
Retained Earnings	$1.37B	$1.39B	$1.94B	$1.89B	$1.84B	$1.81B	$2.12B	$2.05B	$1.96B	·	$1.72B	$1.63B	$1.54B	·	$1.28B	$1.18B
Treasury Stock	$210M	$0	$363M	$363M	$357M	$0	$120M	$18M	$9M	·	$24M	$24M	$19M	·	$38M	$38M
AOCI	$-191M	$-172M	$-192M	$-166M	$-265M	$-317M	$-193M	$-270M	$-250M	·	$-268M	$-208M	$-239M	·	$-396M	$-259M
Stockholders' Equity	$2.94B	$3.16B	$3.41B	$3.35B	$3.19B	$3.46B	$3.78B	$3.72B	$3.64B	·	$3.31B	$3.25B	$3.11B	·	$2.63B	$2.65B
Liabilities + Equity	$7.73B	$7.14B	$7.51B	$7.56B	$7.58B	$7.53B	$8.00B	$7.95B	$8.15B	·	$7.61B	$7.77B	$7.70B	·	$7.38B	$7.53B
Shares Outstanding	48,167,000	49,217,000	49,215,000	49,209,000	49,115,000	51,141,000	51,134,000	51,613,000	51,510,000	·	51,296,000	51,266,000	51,182,000	50,944,000	50,877,000	50,861,000

Cash Flow 16

Quarterly Cash Flow data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$67M	$78M	$85M	$120M	$120M	$102M	$88M	$86M	$85M	$81M	$79M	$78M	$77M	$78M	$75M	$76M
Stock-based Comp	$22M	$18M	$23M	$17M	$13M	$17M	$19M	$17M	$17M	$20M	$23M	·	$13M	$22M	$22M	$15M
Amort. of Intangibles	$15M	$21M	$27M	$65M	$65M	$41M	$32M	$32M	$33M	$34M	$34M	$34M	$35M	$35M	$36M	$38M
Restructuring	$32M	$26M	$17M	$32M	$24M	$41M	$31M	$18M	$17M	$8M	$15M	$3M	$3M	$4M	$1M	$1M
Other Non-cash	$-34M	·	·	·	$13M	·	·	·	$-45M	·	·	·	$-84M	·	·	·
Operating Cash Flow	$41M	$148M	$214M	$205M	$172M	$159M	$252M	$194M	$130M	$221M	$205M	·	$109M	$235M	$133M	$149M
CapEx	$56M	$89M	$36M	$35M	$59M	$76M	$39M	$39M	$79M	$78M	$66M	$67M	$107M	$89M	$72M	$83M
Investing Cash Flow	$-408M	$-93M	$-34M	$-37M	$-45M	$-76M	$-21M	$-62M	$-86M	$-238M	$-80M	·	$-169M	$44M	$-92M	$-462M
Debt Issued	$912M	$157M	$107M	$547M	$416M	$105M	$236M	$440M	$301M	$443M	$51M	·	$192M	$154M	$618M	$1.22B
Net Debt Issued	$912M	·	·	·	$416M	·	·	·	$301M	·	·	·	$192M	·	·	·
Stock Repurchased	$208M	$96.0K	$93.0K	$7M	$353M	$124.0K	$101M	$9M	$9M	$139.0K	$38.0K	·	$19M	$159.0K	$24.0K	$4M
Net Stock Activity	$-208M	·	·	·	$-353M	·	·	·	$-9M	·	·	·	$-19M	·	·	·
Financing Cash Flow	$348M	$-52M	$-153M	$-227M	$-105M	$-76M	$-208M	$-286M	$18M	$124M	$-163M	·	$25M	$-249M	$-52M	$271M
Net Change in Cash	$-18M	$7M	$24M	$-47M	$26M	$-6M	$31M	$-158M	$54M	$119M	$-43M	·	$-32M	$45M	$-11M	$-36M
Taxes Paid	$2M	$27M	$19M	$57M	$17M	$31M	$23M	$53M	$19M	$15M	$14M	·	$14M	·	·	·
Free Cash Flow	$-15M	·	·	·	$112M	·	·	·	$51M	·	·	·	$3M	·	·	·

Profitability 5

Quarterly Profitability data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	12.0%	·	13.3%	9.7%	7.6%	·	11.6%	14.8%	12.4%	·	14.8%	15.6%	16.3%	·	15.3%	19.3%
Net Margin	-1.5%	·	5.4%	5.1%	2.6%	·	6.9%	9.2%	7.2%	·	8.5%	9.2%	10.0%	·	9.8%	11.2%
EBITDA Margin	18.8%	·	21.8%	21.3%	19.8%	·	20.4%	23.2%	20.9%	·	22.4%	22.9%	23.8%	·	22.8%	27.1%
ROA	-0.19%	·	0.70%	0.67%	0.32%	·	0.89%	1.2%	0.92%	·	1.2%	·	·	·	1.3%	1.5%
ROE	-0.48%	·	1.5%	1.5%	0.75%	·	2.0%	2.7%	2.2%	·	2.9%	·	·	·	3.8%	4.4%

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.4	·	1.4	1.4	1.4	·	1.5	1.6	1.7	·	1.5	·	·	·	1.4	1.3
Quick Ratio	0.8	·	0.8	0.9	0.9	·	1.0	1.0	1.2	·	1.0	·	·	·	1.0	0.9
Debt / Equity	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	·	·	·	0.0	0.0
Interest Coverage	·	·	·	·	·	·	·	·	3.6	·	4.5	4.7	4.9	·	13.3	50.6

Efficiency 3

Quarterly Efficiency data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	·	·	·	0.1	0.1
Inventory Turnover	·	·	·	·	·	·	2.1	2.1	2.1	·	·	·	·	·	·	·
Receivables Turnover	1.4	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.3	·	·	·	1.4	1.4

Per Share 5

Quarterly Per Share data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$61.05	·	$69.20	$68.14	$65.04	·	$73.97	$72.13	$70.67	·	$64.45	·	·	·	$51.63	$52.06
Revenue / Share	$20.34	·	$20.33	$20.93	$19.35	·	$19.58	$19.79	$19.51	·	$19.89	$20.59	$20.02	·	$19.29	$18.98
Cash Flow / Share	$0.84	·	·	·	$3.38	·	·	·	$2.51	·	·	·	$2.13	·	·	·
Cash / Share	$3.98	·	$4.21	$3.72	$4.67	·	$4.11	$3.47	$6.35	·	$3.06	·	·	·	$3.81	$3.94
EPS (TTM)	$2.36	·	$3.99	$4.63	$4.87	·	$6.06	$6.62	$6.89	·	$7.47	$7.91	$7.83	·	$7.83	$7.67

Valuation (TTM) 13

Quarterly Valuation (TTM) data for CRL
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$4.02B	·	$4.03B	$4.05B	$4.03B	·	$4.07B	$4.12B	$4.13B	·	$4.11B	$4.05B	$3.91B	·	$3.77B	$3.70B
Net Income TTM	$117M	·	$202M	$242M	$262M	·	$324M	$351M	$360M	·	$384M	$406M	$402M	·	$402M	$394M
Market Cap	$7.67B	·	$7.31B	$7.38B	$7.64B	·	$10.14B	$10.66B	$13.96B	·	$10.05B	·	·	·	$9.54B	$11.51B
Enterprise Value	$7.48B	·	$7.10B	$7.20B	$7.41B	·	$9.93B	$10.48B	$13.63B	·	$9.90B	·	·	·	$9.35B	$11.31B
P/E	67.4	·	37.2	32.4	31.9	·	32.7	31.2	39.3	·	26.2	26.6	25.8	·	23.9	29.5
P/S	1.9	·	1.8	1.8	1.9	·	2.5	2.6	3.4	·	2.4	·	·	·	2.5	3.1
P/B	2.6	·	2.1	2.2	2.4	·	2.7	2.9	3.8	·	3.0	·	·	·	3.6	4.3
P / Cash Flow	186.6	·	·	·	44.5	·	·	·	107.5	·	·	·	·	·	·	·
P / FCF	-516.9	·	·	·	68.0	·	·	·	275.0	·	·	·	·	·	·	·
EV / EBITDA	40.0	·	32.4	32.8	38.0	·	48.3	44.1	64.5	·	43.0	·	·	·	41.4	42.9
EV / FCF	-504.4	·	·	·	65.9	·	·	·	268.6	·	·	·	·	·	·	·
EV / Revenue	1.9	·	1.8	1.8	1.8	·	2.4	2.5	3.3	·	2.4	·	·	·	2.5	3.1
Earnings Yield	1.5%	·	2.7%	3.1%	3.1%	·	3.1%	3.2%	2.5%	·	3.8%	3.8%	3.9%	·	4.2%	3.4%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2025-12-27	2024-12-28	2023-12-30	2022-12-31	2021-12-25
Revenue	$4.02B	$4.05B	$4.13B	$3.98B	$3.54B
Operating Margin %	0.63%	5.6%	14.9%	16.4%	16.7%
Net Income	$-144M	$22M	$475M	$486M	$391M
Diluted EPS	$-2.91	$0.20	$9.22	$9.48	$7.60

Balance Sheet

	2025-12-27	2024-12-28	2023-12-30	2022-12-31	2021-12-25
Debt / Equity	0.0	0.0	0.0	0.0	0.0
Current Ratio	1.3	1.4	1.5	1.3	1.2
Quick Ratio	0.8	0.9	1.0	0.9	0.9

Cash Flow

	2025-12-27	2024-12-28	2023-12-30	2022-12-31	2021-12-25
Free Cash Flow	$518M	$502M	$365M	$295M	$532M

Latest News Recent headlines mentioning this company

Charles River Laboratories International Q1 Earnings Call Highlights Yahoo Finance · 1 week, 4 days ago
Tokenized Crypto US Treasuries Near $14 Billion as Circle and BlackRock Lead Growth Yahoo Finance · 1 month ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

CRL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

CRL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

CRL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer Comparison Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals